Form D · Pharmaceuticals
Minnesota Medical Solutions LLC
Edina, MN · CIK 0001632022
Offering snapshot reported Apr 17, 2015 · SEC filing
- Reported sold
- $3.61M Offering amount: $3.61M
- Investors reported
- 28 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 23, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 17, 2015 | Initial | $3,610,000 | No comparison | 28 | SEC filing |
| Apr 17, 2015 | Initial | $13,000,000 | No comparison | 83 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-238226
Source: Form D, filed Apr 17, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Bultman | Director |
| Brooke Gehring | Director |
| Ross Hussey | Executive, Promoter |
| Kyle Kingsley | Director, Executive, Promoter |
| Charles Ledermann | Director |
| Jon Thompson | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5200 Willson Road, Suite 150
Edina, MN, 55424
Edina, MN, 55424